SecBot SecBot
SECBOTREPLAY Home › Report › NAMS

NAMS · CEO Michael Davidson purchased $227K of NAMS stock on the open market…

NewAmsterdam Pharma Co N.V. · INSIDER-BUY filed Sep 15, 2026 at 16:30 ET

At the news

BULLISHIMPACT 5/10

INSIDER-BUY filed Sep 15, 2026 at 16:30 ET

CEO Michael Davidson purchased $227K of NAMS stock on the open market at $22.65/share, a standalone conviction buy. This is a bullish signal from the highest-ranking insider, though the dollar amount is modest relative to the $2.5B market cap (~0.009%). The buy is not part of a 10b5-1 plan and comes amid strong analyst consensus (91% bullish).

  • CEO Michael H. Davidson purchased 10,000 shares of NAMS at $22.65/share on 2026-09-14, totaling $227K.
  • The purchase is an open-market buy (SEC Form 4 code P), not a 10b5-1 plan or grant.
  • Market cap is $2.5B; the buy represents ~0.009% of market cap, below the 0.1% materiality threshold.
  • Analyst consensus is 91% bullish (9 Strong Buy, 12 Buy, 2 Hold).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access